A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study
PLOS ONE · 30.08.2024 · 19 (8) · e0299770
DOI: 10.1371/journal.pone.0299770 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 30.08.2024. Verfasst von Aseel S Abuzour und 24 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit for Ageing & Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, University of Leeds, Bradford, United Kingdom. Hauptthemen laut MEDLINE: Primary Health Care, Focus Groups, Polypharmacy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Health and Care Research Wales, National Institute for Health and Care Research ARC NWC.
Abstract (Originalsprache)
Introduction
Structured medication reviews (SMRs), introduced in the United Kingdom (UK) in 2020, aim to enhance shared decision-making in medication optimisation, particularly for patients with multimorbidity and polypharmacy. Despite its potential, there is limited empirical evidence on the implementation of SMRs, and the challenges faced in the process. This study is part of a larger DynAIRx (Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity) project which aims to introduce Artificial Intelligence (AI) to SMRs and develop machine learning models and visualisation tools for patients with multimorbidity. Here, we explore how SMRs are currently undertaken and what barriers are experienced by those involved in them.
Methods
Qualitative focus groups and semi-structured interviews took place between 2022–2023. Six focus groups were conducted with doctors, pharmacists and clinical pharmacologists (n = 21), and three patient focus groups with patients with multimorbidity (n = 13). Five semi-structured interviews were held with 2 pharmacists, 1 trainee doctor, 1 policy-maker and 1 psychiatrist. Transcripts were analysed using thematic analysis.
Results
Two key themes limiting the effectiveness of SMRs in clinical practice were identified: ‘Medication Reviews in Practice’ and ‘Medication-related Challenges’. Participants noted limitations to the efficient and effectiveness of SMRs in practice including the scarcity of digital tools for identifying and prioritising patients for SMRs; organisational and patient-related challenges in inviting patients for SMRs and ensuring they attend; the time-intensive nature of SMRs, the need for multiple appointments and shared decision-making; the impact of the healthcare context on SMR delivery; poor communication and data sharing issues between primary and secondary care; difficulties in managing mental health medications and specific challenges associated with anticholinergic medication.
Conclusion
SMRs are complex, time consuming and medication optimisation may require multiple follow-up appointments to enable a comprehensive review. There is a need for a prescribing support system to identify, prioritise and reduce the time needed to understand the patient journey when dealing with large volumes of disparate clinical information in electronic health records. However, monitoring the effects of medication optimisation changes with a feedback loop can be challenging to establish and maintain using current electronic health record systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Academic Unit for Ageing & Stroke Research, Bradford Teaching Hospitals NHS Foundation Trust, University of Leeds, Bradford, United Kingdom.
- Faculty of Medicine and Health, School of Medicine, University of Leeds, Leeds, United Kingdom.
- Institute of Population Health, University of Liverpool, Liverpool, United Kingdom.
- Directorate of Mental Health and Learning Disabilities, Powys Teaching Health Board, Bronllys, United Kingdom.
- General Practice and Primary Care, School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
- Leeds Institute for Data Analytics, University of Leeds, Leeds, United Kingdom.
ORCID-Profile: Aseel S Abuzour, Frances S Mair, Asra Aslam, Harriet Cant, Layik Hama, Gary Leeming, Maurice O'Connell, Olusegun Popoola, Pieta Schofield, Iain Buchan, Lauren E Walker
Förderung
- National Institute for Health and Care Research
- Health and Care Research Wales
- National Institute for Health and Care Research ARC NWC
Zitieren
APA
Abuzour, A. S., Wilson, S. A., Woodall, A. A., Mair, F. S., Clegg, A., Shantsila, E., Gabbay, M., Abaho, M., Aslam, A., Bollegala, D., Cant, H., Griffiths, A., Hama, L., Leeming, G., Lo, E., Maskell, S., O'Connell, M., Popoola, O., Relton, S., …, & Walker, L. E. (2024). A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study. PLOS ONE, 19(8), e0299770. https://doi.org/10.1371/journal.pone.0299770
Vancouver
Abuzour AS, Wilson SA, Woodall AA, Mair FS, Clegg A, Shantsila E, et al. A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study. PLOS ONE. 2024;19(8):e0299770. doi:10.1371/journal.pone.0299770
BibTeX
@article{Abuzour2024,
author = {Abuzour, Aseel S and Wilson, Samantha A and Woodall, Alan A and Mair, Frances S and Clegg, Andrew and Shantsila, Eduard and Gabbay, Mark and Abaho, Michael and Aslam, Asra and Bollegala, Danushka and Cant, Harriet and Griffiths, Alan and Hama, Layik and Leeming, Gary and Lo, Emma and Maskell, Simon and O'Connell, Maurice and Popoola, Olusegun and Relton, Samuel and Ruddle, Roy A and Schofield, Pieta and Sperrin, Matthew and Staa, Tjeerd Van and Buchan, Iain and Walker, Lauren E},
title = {A qualitative exploration of barriers to efficient and effective structured medication reviews in primary care: Findings from the DynAIRx study},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {8},
pages = {e0299770},
doi = {10.1371/journal.pone.0299770}
}
EUVIMED